Attached files

file filename
10-K - FORM 10-K - SPECTRUM PHARMACEUTICALS INCa58896e10vk.htm
EX-21 - EX-21 - SPECTRUM PHARMACEUTICALS INCa58896exv21.htm
EX-3.1 - EX-3.1 - SPECTRUM PHARMACEUTICALS INCa58896exv3w1.htm
EX-23.2 - EX-23.2 - SPECTRUM PHARMACEUTICALS INCa58896exv23w2.htm
EX-10.1 - EX-10.1 - SPECTRUM PHARMACEUTICALS INCa58896exv10w1.htm
EX-10.6 - EX-10.6 - SPECTRUM PHARMACEUTICALS INCa58896exv10w6.htm
EX-10.35 - EX-10.35 - SPECTRUM PHARMACEUTICALS INCa58896exv10w35.htm
EX-10.18 - EX-10.18 - SPECTRUM PHARMACEUTICALS INCa58896exv10w18.htm
EX-10.34 - EX-10.34 - SPECTRUM PHARMACEUTICALS INCa58896exv10w34.htm
EX-10.19 - EX-10.19 - SPECTRUM PHARMACEUTICALS INCa58896exv10w19.htm
EX-31.2 - EX-31.2 - SPECTRUM PHARMACEUTICALS INCa58896exv31w2.htm
EX-32.2 - EX-32.2 - SPECTRUM PHARMACEUTICALS INCa58896exv32w2.htm
EX-32.1 - EX-32.1 - SPECTRUM PHARMACEUTICALS INCa58896exv32w1.htm
EX-31.1 - EX-31.1 - SPECTRUM PHARMACEUTICALS INCa58896exv31w1.htm
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-3 Nos. 333-163366, 333-150260, 333-142628, 333-135029, 333-125208, 333-121612, 333-115759, 333-110103, 333-108658, 333-105814, 333-102587, 333-64444, 333-64432, 333-60966, 333-51388, 333-42852, 333-38710, 333-37180, 333-92855, 333-73009, 333-52331, 333-37585; and Form S-8 Nos. 333-160312, 333-160705, 333-164014, 333-134566, 333-119833, 333-106427, 333-54246, 333-30345) of Spectrum Pharmaceuticals, Inc. and Subsidiaries and in the related Prospectuses of our reports dated March 9, 2011, with respect to the 2010 and 2009 consolidated financial statements of Spectrum Pharmaceuticals, Inc. and Subsidiaries and the effectiveness of internal control over financial reporting of Spectrum Pharmaceuticals, Inc. and Subsidiaries, included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
 
/s/ Ernst & Young, LLP
Irvine, California
March 9, 2011